Viking Therapeutics to Participate in 19th Annual Needham Healthcare Conference
(WorldNews Health)

SAN DIEGO, April 7, 2020/PRNewswire / -- Viking Therapeutics, Inc. (`Viking`) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in the Needham & Company 19th Annual Healthcare Conference. The conference, which will take place April 14-15, 2020, is being conducted with a virtual format. Details of the company`s participation are as...